| High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis S Eyre, J Bowes, D Diogo, A Lee, A Barton, P Martin, A Zhernakova, ... Nature genetics 44 (12), 1336-1340, 2012 | 782 | 2012 |
| Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial JD Leuppi, P Schuetz, R Bingisser, M Bodmer, M Briel, T Drescher, ... Jama 309 (21), 2223-2231, 2013 | 607 | 2013 |
| Genetics and epigenetics of rheumatoid arthritis S Viatte, D Plant, S Raychaudhuri Nature Reviews Rheumatology 9 (3), 141-153, 2013 | 515 | 2013 |
| Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis G Palmer, D Talabot‐Ayer, C Lamacchia, D Toy, CA Seemayer, S Viatte, ... Arthritis & rheumatism: official journal of the American College of …, 2009 | 405 | 2009 |
| Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway JC Lee, M Espeli, CA Anderson, MA Linterman, JM Pocock, NJ Williams, ... Cell 155 (1), 57-69, 2013 | 267 | 2013 |
| Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response S Viatte, D Plant, B Han, B Fu, A Yarwood, W Thomson, DPM Symmons, ... Jama 313 (16), 1645-1656, 2015 | 222 | 2015 |
| Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis K Ishigaki, S Sakaue, C Terao, Y Luo, K Sonehara, K Yamaguchi, ... Nature genetics 54 (11), 1640-1651, 2022 | 219 | 2022 |
| Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors DB Miklos, HT Kim, E Zorn, EP Hochberg, L Guo, A Mattes-Ritz, S Viatte, ... Blood 103 (1), 353-359, 2004 | 185 | 2004 |
| Genetics of rheumatoid arthritis susceptibility, severity, and treatment response S Viatte, A Barton Seminars in immunopathology 39 (4), 395-408, 2017 | 154 | 2017 |
| Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients S Viatte, D Plant, J Bowes, M Lunt, S Eyre, A Barton, J Worthington Annals of the rheumatic diseases 71 (12), 1984-1990, 2012 | 154 | 2012 |
| Adalimumab in severe and acute sciatica: A multicenter, randomized, double‐blind, placebo‐controlled trial S Genevay, S Viatte, A Finckh, P Zufferey, F Balagué, C Gabay Arthritis & rheumatism 62 (8), 2339-2346, 2010 | 83 | 2010 |
| Reverse immunology approach for the identification of CD8 T‐cell‐defined antigens: Advantages and hurdles S Viatte, PM Alves, P Romero Immunology and cell biology 84 (3), 318-330, 2006 | 72 | 2006 |
| Brief Report: Identification of BACH2 and RAD51B as Rheumatoid Arthritis Susceptibility Loci in a Meta‐Analysis of Genome‐Wide Data K McAllister, A Yarwood, J Bowes, G Orozco, S Viatte, D Diogo, ... Arthritis & Rheumatism 65 (12), 3058-3062, 2013 | 64* | 2013 |
| Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis EMA Hensor, P McKeigue, SF Ling, M Colombo, JH Barrett, JL Nam, ... Rheumatology 58 (8), 1400-1409, 2019 | 61 | 2019 |
| Replication of associations of genetic loci outside the HLA region with susceptibility to anti–cyclic citrullinated peptide–negative rheumatoid arthritis S Viatte, J Massey, J Bowes, K Duffus, arcOGEN Consortium, S Eyre, ... Arthritis & rheumatology 68 (7), 1603-1613, 2016 | 59 | 2016 |
| Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial S Genevay, A Finckh, P Zufferey, S Viatte, F Balagué, C Gabay Annals of the rheumatic diseases 71 (4), 560-562, 2012 | 55 | 2012 |
| Identification of tumor-associated antigens by large-scale analysis of genes expressed in human colorectal cancer PMS Alves, N Lévy, BJ Stevenson, H Bouzourene, G Theiler, G Bricard, ... Cancer immunity 8 (1), 11, 2008 | 55 | 2008 |
| Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer PMS Alves, N Lévy, H Bouzourene, S Viatte, G Bricard, M Ayyoub, ... Cancer Immunology, Immunotherapy 56, 839-847, 2007 | 55 | 2007 |
| Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome‐wide association study G Orozco, S Viatte, J Bowes, P Martin, AG Wilson, AW Morgan, S Steer, ... Arthritis & rheumatology 66 (1), 24-30, 2014 | 51 | 2014 |
| Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis ML Burr, S Viatte, M Bukhari, D Plant, DP Symmons, W Thomson, ... Arthritis research & therapy 14, 1-10, 2012 | 49 | 2012 |
